232 related articles for article (PubMed ID: 26959126)
41. Stem cells: a new paradigm for disease modeling and developing therapies for age-related macular degeneration.
Melville H; Carpiniello M; Hollis K; Staffaroni A; Golestaneh N
J Transl Med; 2013 Mar; 11():53. PubMed ID: 23452406
[TBL] [Abstract][Full Text] [Related]
42. Stargardt macular dystrophy and evolving therapies.
Hussain RM; Ciulla TA; Berrocal AM; Gregori NZ; Flynn HW; Lam BL
Expert Opin Biol Ther; 2018 Oct; 18(10):1049-1059. PubMed ID: 30129371
[TBL] [Abstract][Full Text] [Related]
43. Stem cells in retinal regeneration: past, present and future.
Ramsden CM; Powner MB; Carr AJ; Smart MJ; da Cruz L; Coffey PJ
Development; 2013 Jun; 140(12):2576-85. PubMed ID: 23715550
[TBL] [Abstract][Full Text] [Related]
44. Stem cell therapies for age-related macular degeneration: the past, present, and future.
Dang Y; Zhang C; Zhu Y
Clin Interv Aging; 2015; 10():255-64. PubMed ID: 25609937
[TBL] [Abstract][Full Text] [Related]
45. [Preclinical Study of Human Induced Pluripotent Stem Cell-derived Retinal Pigment Epithelium Cell Sheets Transplantation].
Kamao H
Nippon Ganka Gakkai Zasshi; 2016 Nov; 120(11):754-63. PubMed ID: 30074740
[TBL] [Abstract][Full Text] [Related]
46. Features specific to retinal pigment epithelium cells derived from three-dimensional human embryonic stem cell cultures - a new donor for cell therapy.
Wu W; Zeng Y; Li Z; Li Q; Xu H; Yin ZQ
Oncotarget; 2016 Apr; 7(16):22819-33. PubMed ID: 27009841
[TBL] [Abstract][Full Text] [Related]
47. Molecular profiling of stem cell-derived retinal pigment epithelial cell differentiation established for clinical translation.
Petrus-Reurer S; Lederer AR; Baqué-Vidal L; Douagi I; Pannagel B; Khven I; Aronsson M; Bartuma H; Wagner M; Wrona A; Efstathopoulos P; Jaberi E; Willenbrock H; Shimizu Y; Villaescusa JC; André H; Sundstrӧm E; Bhaduri A; Kriegstein A; Kvanta A; La Manno G; Lanner F
Stem Cell Reports; 2022 Jun; 17(6):1458-1475. PubMed ID: 35705015
[TBL] [Abstract][Full Text] [Related]
48. Human Embryonic Stem Cell-Derived Retinal Pigment Epithelium-Role in Dead Cell Clearance and Inflammation.
Szatmári-Tóth M; Ilmarinen T; Mikhailova A; Skottman H; Kauppinen A; Kaarniranta K; Kristóf E; Lytvynchuk L; Veréb Z; Fésüs L; Petrovski G
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791639
[TBL] [Abstract][Full Text] [Related]
49. Tumorigenicity studies of induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) for the treatment of age-related macular degeneration.
Kanemura H; Go MJ; Shikamura M; Nishishita N; Sakai N; Kamao H; Mandai M; Morinaga C; Takahashi M; Kawamata S
PLoS One; 2014; 9(1):e85336. PubMed ID: 24454843
[TBL] [Abstract][Full Text] [Related]
50. Induced pluripotent stem cell therapies for geographic atrophy of age-related macular degeneration.
Du H; Lim SL; Grob S; Zhang K
Semin Ophthalmol; 2011 May; 26(3):216-24. PubMed ID: 21609235
[TBL] [Abstract][Full Text] [Related]
51. Honeycomb porous films as permeable scaffold materials for human embryonic stem cell-derived retinal pigment epithelium.
Calejo MT; Ilmarinen T; Jongprasitkul H; Skottman H; Kellomäki M
J Biomed Mater Res A; 2016 Jul; 104(7):1646-56. PubMed ID: 26914698
[TBL] [Abstract][Full Text] [Related]
52. Survival of Transplanted Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells in a Human Recipient for 22 Months.
Shim SH; Kim G; Lee DR; Lee JE; Kwon HJ; Song WK
JAMA Ophthalmol; 2017 Mar; 135(3):287-289. PubMed ID: 28196199
[No Abstract] [Full Text] [Related]
53. Restoring Vision Using Stem Cells and Transplantation.
Cuevas E; Parmar P; Sowden JC
Adv Exp Med Biol; 2019; 1185():563-567. PubMed ID: 31884671
[TBL] [Abstract][Full Text] [Related]
54. Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation.
Vugler A; Carr AJ; Lawrence J; Chen LL; Burrell K; Wright A; Lundh P; Semo M; Ahmado A; Gias C; da Cruz L; Moore H; Andrews P; Walsh J; Coffey P
Exp Neurol; 2008 Dec; 214(2):347-61. PubMed ID: 18926821
[TBL] [Abstract][Full Text] [Related]
55. Concise Review: Making Stem Cells Retinal: Methods for Deriving Retinal Pigment Epithelium and Implications for Patients With Ocular Disease.
Leach LL; Clegg DO
Stem Cells; 2015 Aug; 33(8):2363-73. PubMed ID: 25809736
[TBL] [Abstract][Full Text] [Related]
56. Cell-Based Therapies for Age-Related Macular Degeneration.
Khateb S; Jha S; Bharti K; Banin E
Adv Exp Med Biol; 2021; 1256():265-293. PubMed ID: 33848006
[TBL] [Abstract][Full Text] [Related]
57. Fluorescence Lifetime Patterns of Retinal Pigment Epithelium Atrophy in Patients with Stargardt Disease and Age-Related Macular Degeneration.
Solberg Y; Dysli C; Escher P; Berger L; Wolf S; Zinkernagel MS
Ophthalmologica; 2020; 243(3):195-206. PubMed ID: 31743906
[TBL] [Abstract][Full Text] [Related]
58. Penetration, distribution, and elimination of remofuscin/soraprazan in Stargardt mouse eyes following a single intravitreal injection using pharmacokinetics and transmission electron microscopic autoradiography: Implication for the local treatment of Stargardt's disease and dry age-related macular degeneration.
Julien-Schraermeyer S; Illing B; Tschulakow A; Taubitz T; Guezguez J; Burnet M; Schraermeyer U
Pharmacol Res Perspect; 2020 Dec; 8(6):e00683. PubMed ID: 33164337
[TBL] [Abstract][Full Text] [Related]
59. [Autologous transplantation of retinal pigment epithelium in age related macular degeneration].
Siqueira RC
Arq Bras Oftalmol; 2009; 72(1):123-30. PubMed ID: 19347139
[TBL] [Abstract][Full Text] [Related]
60. Survival of an HLA-mismatched, bioengineered RPE implant in dry age-related macular degeneration.
Kashani AH; Lebkowski JS; Hinton DR; Zhu D; Faynus MA; Chen S; Rahhal FM; Avery RL; Salehi-Had H; Chan C; Palejwala N; Ingram A; Dang W; Lin CM; Mitra D; Martinez-Camarillo JC; Bailey J; Arnold C; Pennington BO; Rao N; Johnson LV; Clegg DO; Humayun MS
Stem Cell Reports; 2022 Mar; 17(3):448-458. PubMed ID: 35120620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
